Literature DB >> 33941795

Machine learning applied to near-infrared spectra for clinical pleural effusion classification.

Zhongjian Chen1,2,3,4, Keke Chen1,2,3,4, Yan Lou5, Jing Zhu1,2,3, Weimin Mao6,7,8, Zhengbo Song9,10,11.   

Abstract

Lung cancer patients with malignant pleural effusions (MPE) have a particular poor prognosis. It is crucial to distinguish MPE from benign pleural effusion (BPE). The present study aims to develop a rapid, convenient and economical diagnostic method based on FTIR near-infrared spectroscopy (NIRS) combined with machine learning strategy for clinical pleural effusion classification. NIRS spectra were recorded for 47 MPE samples and 35 BPE samples. The sample data were randomly divided into train set (n = 62) and test set (n = 20). Partial least squares, random forest, support vector machine (SVM), and gradient boosting machine models were trained, and subsequent predictive performance were predicted on the test set. Besides the whole spectra used in modeling, selected features using SVM recursive feature elimination algorithm were also investigated in modeling. Among those models, NIRS combined with SVM showed the best predictive performance (accuracy: 1.0, kappa: 1.0, and AUCROC: 1.0). SVM with the top 50 feature wavenumbers also displayed a high predictive performance (accuracy: 0.95, kappa: 0.89, AUCROC: 0.99). Our study revealed that the combination of NIRS and machine learning is an innovative, rapid, and convenient method for clinical pleural effusion classification, and worth further evaluation.

Entities:  

Year:  2021        PMID: 33941795     DOI: 10.1038/s41598-021-87736-4

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  16 in total

Review 1.  Variables selection methods in near-infrared spectroscopy.

Authors:  Zou Xiaobo; Zhao Jiewen; Malcolm J W Povey; Mel Holmes; Mao Hanpin
Journal:  Anal Chim Acta       Date:  2010-03-30       Impact factor: 6.558

2.  Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.

Authors:  Guang-Ping Wu; Jing Ba; Yu-Jie Zhao; En-Hua Wang
Journal:  Acta Cytol       Date:  2007 Jul-Aug       Impact factor: 2.319

Review 3.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

4.  Metabonomic classification and detection of small molecule biomarkers of malignant pleural effusions.

Authors:  Xian-Mei Zhou; Cui-Cui He; Yu-Mei Liu; Yang Zhao; Dan Zhao; Yun Du; Wei-Yi Zheng; Jian-Xin Li
Journal:  Anal Bioanal Chem       Date:  2012-09-29       Impact factor: 4.142

Review 5.  Current best practice in the evaluation and management of malignant pleural effusions.

Authors:  Steven Walker; Anna C Bibby; Nick A Maskell
Journal:  Ther Adv Respir Dis       Date:  2016-10-24       Impact factor: 4.031

6.  Potential biomarkers for antidiastole of tuberculous and malignant pleural effusion by proteome analysis.

Authors:  Jing Shi; Pu Li; Lijin Zhou; Suwen Qi; Bo Wang; Dandan Li; Liang Duan; Wei Xian Chen; Jirong Xia; Lin Zou; Shuangshuang Yang
Journal:  Biomark Med       Date:  2019-02-22       Impact factor: 2.851

7.  Pleural effusion as an indicator of short term mortality in acute pulmonary embolism.

Authors:  Şehnaz Olgun Yıldızeli; Umut Sabri Kasapoğlu; Hüseyin Arıkan; Canan Çimşit; Nuri Çagatay Çimşit; Melek Süzer Aslan; Derya Kocakaya; Emel Eryüksel; Berrin Ceyhan; Sait Karakurt
Journal:  Tuberk Toraks       Date:  2018-09

8.  Metabolomic analysis based on 1H-nuclear magnetic resonance spectroscopy metabolic profiles in tuberculous, malignant and transudative pleural effusion.

Authors:  Cheng Wang; Jingjin Peng; Yanling Kuang; Jiaqiang Zhang; Luming Dai
Journal:  Mol Med Rep       Date:  2017-06-12       Impact factor: 2.952

9.  Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion.

Authors:  Jeong Uk Lim; Chang Dong Yeo; Hye Seon Kang; Chan Kwon Park; Ju Sang Kim; Jin Woo Kim; Seung Joon Kim; Sang Haak Lee
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

Review 10.  The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non‑small cell lung cancer (Review).

Authors:  Yao Chen; Nicholas W Mathy; Hongda Lu
Journal:  Mol Med Rep       Date:  2018-04-23       Impact factor: 2.952

View more
  1 in total

1.  Optimal Modeling of Anti-Breast Cancer Candidate Drugs Based on Graph Model Feature Selection.

Authors:  Rongyuan Chen; Zhixiong He; Shaonian Huang; Lizhi Shen; Xiancheng Zhou
Journal:  Comput Math Methods Med       Date:  2022-08-30       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.